Olympus Corporation - 7733.T

7733.T Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
7733.T	-0.4	-2.2	-2.5	-18.8	-15.6	2.7	-3.5	29.9	121.3	842.4
S&P 500	1.0	3.7	2.1	2.3	8.2	25.4	31.0	80.6	196.5	33856.2

Compare 7733.T with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	7733.T
name	Olympus Corporation
price	2290
changes percentage	-0.4348
change	-10
day low	2252
day high	2295
year high	2867
year low	1935.5
market cap	2619669233560
price avg 50	2408.63
price avg 200	2509.25
exchange	JPX
volume	2704900
avg volume	3979888
open	2288
previous close	2300
eps	74.47
pe	30.75
earnings announcement	2025-02-14T06:00:00.000+0000
shares outstanding	1143960364
timestamp	2025-01-17 06:45:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 63.7%

Overall Quarterly Financial Health: 49.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	936210000000	881923000000	6.16
gross profit	589830000000	596849000000	-1.18
gross profit ratio	0.63	0.68	-6.91
research and development expenses	80727000000	76900000000	4.98
operating expenses	581525000000	410731000000	41.58
interest income	2365000000	3860000000	-38.73
interest expense	10306000000	8175000000	26.07
ebitda	107971000000	238825000000	-54.79
ebitdaratio	0.12	0.29	-60.46
operating income	43598000000	186609000000	-76.64
operating income ratio	0.05	0.21	-77.99
net income	242566000000	143432000000	69.12
net income ratio	0.26	0.16	59.31
eps	199.91	113.22	76.57

Overall Score of Annual Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 936,210 million in 2023 from 881,923 million in 2022 representing a change of 6.16%. This indicates a sales growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 80,727 million in 2023 from 76,900 million in 2022 representing a change of 4.98%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 43,598 million in 2023 from 186,609 million in 2022 representing a change of -76.64%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 242,566 million in 2023 from 143,432 million in 2022 representing a change of 69.12%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 199.91 in 2023 from 199.91 in 2022 representing a change of 76.57%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 589,830 million in 2023 from 596,849 million in 2022 representing a change of -1.18%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 581,525 million in 2023 from 410,731 million in 2022 representing a change of 41.58%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 107,971 million in 2023 from 238,825 million in 2022 representing a change of -54.79%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	239208000000	234821000000	1.87
gross profit	166750000000	156206000000	6.75
gross profit ratio	0.7	0.67	4.79
research and development expenses	0	24010000000	-100.00
operating expenses	123697000000	128729000000	-3.91
interest income	784000000	1094000000	-28.34
interest expense	1430000000	2173000000	-34.19
ebitda	43837000000	44800000000	-2.15
ebitdaratio	0.18	0.19	-3.94
operating income	43053000000	27477000000	56.69
operating income ratio	0.18	0.12	53.81
net income	34395000000	14583000000	135.86
net income ratio	0.14	0.06	131.53
eps	29.82	12.51	138.37

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 239,208 million in 2024Q2 from 234,821 million in 2024Q1 representing a change of 1.87%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 166,750 million in 2024Q2 from 156,206 million in 2024Q1 representing a change of 6.75%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 123,697 million in 2024Q2 from 128,729 million in 2024Q1 representing a change of -3.91%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Operating Income: Operating income increased to 43,053 million in 2024Q2 from 27,477 million in 2024Q1 representing a change of 56.69%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 34,395 million in 2024Q2 from 14,583 million in 2024Q1 representing a change of 135.86%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 29.82 in 2024Q2 from 29.82 in 2024Q1 representing a change of 138.37%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q2 from 24,010 million in 2024Q1 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 43,837 million in 2024Q2 from 44,800 million in 2024Q1 representing a change of -2.15%. The decrease in EBITDA indicates declined operational efficiency and profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	1534216000000	1508308000000	1.72
total liabilities	777030000000	867074000000	-10.38
total equity	757186000000	641234000000	18.08
cash and cash equivalents	340933000000	169329000000	101.34
short term investments	192682000000	11360000000	1596.14
long term investments	90389000000	88989000000	1.57
total current assets	800340000000	726357000000	10.19
total non current assets	733876000000	781951000000	-6.15
total current liabilities	431695000000	461892000000	-6.54
total non current liabilities	345335000000	405182000000	-14.77
common stock	124643000000	124643000000	0.00
retained earnings	493401000000	371064000000	32.97
total debt	299616000000	340057000000	-11.89

Overall Score of Annual Balance Sheet

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,534,216 million in 2023 from 1,508,308 million in 2022 representing a change of 1.72%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 777,030 million in 2023 from 867,074 million in 2022 representing a change of -10.38%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 757,186 million in 2023 from 641,234 million in 2022 representing a change of 18.08%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 340,933 million in 2023 from 169,329 million in 2022 representing a change of 101.34%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 192,682 million in 2023 from 11,360 million in 2022 representing a change of 1596.14%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 800,340 million in 2023 from 726,357 million in 2022 representing a change of 10.19%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 431,695 million in 2023 from 461,892 million in 2022 representing a change of -6.54%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 493,401 million in 2023 from 371,064 million in 2022 representing a change of 32.97%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 299,616 million in 2023 from 340,057 million in 2022 representing a change of -11.89%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	1366645000000	1515386000000	-9.82
total liabilities	663553000000	725328000000	-8.52
total equity	703092000000	790058000000	-11.01
cash and cash equivalents	245869000000	274408000000	-10.40
short term investments	29022000000	10017000000	189.73
long term investments	10666000000	108711000000	-90.19
total current assets	657065000000	736623000000	-10.80
total non current assets	709580000000	778763000000	-8.88
total current liabilities	419575000000	419194000000	0.09
total non current liabilities	243978000000	306134000000	-20.30
common stock	124643000000	124643000000	0.00
retained earnings	444175000000	409949000000	8.35
total debt	245482000000	254554000000	-3.56

Overall Score of Quarterly Balance Sheet

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 1,366,645 million in 2024Q2 from 1,515,386 million in 2024Q1 representing a change of -9.82%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 703,092 million in 2024Q2 from 790,058 million in 2024Q1 representing a change of -11.01%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 245,869 million in 2024Q2 from 274,408 million in 2024Q1 representing a change of -10.4%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 657,065 million in 2024Q2 from 736,623 million in 2024Q1 representing a change of -10.8%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 419,575 million in 2024Q2 from 419,194 million in 2024Q1 representing a change of 0.09%. This indicates a higher short-term debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 663,553 million in 2024Q2 from 725,328 million in 2024Q1 representing a change of -8.52%. This indicates a decrease in overall liabilities.

  Short Term Investments: Short Term Investments increased to 29,022 million in 2024Q2 from 10,017 million in 2024Q1 representing a change of 189.73%. This indicates an increase in short-term investment holdings.

  Retained Earnings: Retained Earnings increased to 444,175 million in 2024Q2 from 409,949 million in 2024Q1 representing a change of 8.35%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 245,482 million in 2024Q2 from 254,554 million in 2024Q1 representing a change of -3.56%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	135421000000	-97060000000	239.52
operating cash flow	42365000000	98490000000	-56.99
free cash flow	-22259000000	27867000000	-179.88
capital expenditure	-64624000000	-70623000000	8.49
depreciation and amortization	65940000000	66741000000	-1.20
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	-5935000000	8770000000	-167.67
inventory	-19072000000	-26852000000	28.97
acquisitions net	383769000000	-3859000000	10044.78
investments in property plant and equipment	-46425000000	-70623000000	34.26
net cash used for investing activites	359992000000	-58414000000	716.28
debt repayment	-50003000000	-53614000000	6.74
common stock issued	0	0	NaN
common stock repurchased	-180002000000	-50003000000	-259.98
dividends paid	-20057000000	-17822000000	-12.54
net cash used provided by financing activities	-276010000000	-143178000000	-92.77
cash at end of period	340933000000	205512000000	65.89
accounts receivables	-11851000000	-27013000000	56.13
cash at beginning of period	205512000000	302572000000	-32.08

Overall Score of Annual Cashflow Statement

0.29 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 135,421 million in 2023 from -97,060 million in 2022 representing a change of 239.52%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Payables: The absolute value of Accounts Payables decreased to 5,935 million in 2023 from 8,770 million in 2022 representing a change of -167.67%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 42,365 million in 2023 from 98,490 million in 2022 representing a change of -56.99%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -22,259 million in 2023 from 27,867 million in 2022 representing a change of -179.88%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -64,624 million in 2023 from -70,623 million in 2022 representing a change of 8.49%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to -11,851 in 2023 from -27,013 million in 2022 representing a change of 56.13%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -20,057 million in 2023 from -17,822 million in 2022 representing a change of -12.54%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q1	2023Q4	Q/Q change %
0000000000
operating cash flow	23257000000	55226000000	-57.89
free cash flow	14818000000	36435000000	-59.33
capital expenditure	-8439000000	-18791000000	55.09
depreciation and amortization	17186000000	16805000000	2.27
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	14214000000	-25374000000	156.02
accounts payables	0	114000000	-100.00
inventory	19000000	1884000000	-98.99
acquisitions net	0	378159000000	-100.00
investments in property plant and equipment	-8439000000	-18791000000	55.09
net cash used for investing activites	-15160000000	-34374000000	55.90
debt repayment	-55999000000	-10000000000	-459.99
common stock issued	0	0	NaN
common stock repurchased	0	-20002000000	100.00
dividends paid	-20981000000	0	NaN
net cash used provided by financing activities	-77478000000	-32304000000	-139.84
net change in cash	275962000000	-200321000000	237.76
cash at end of period	275962000000	148251000000	86.15
cash at beginning of period	0	348572000000	-100.00

Overall Score of Quarterly Cashflow Statement

0.29 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 275,962 million in 2024Q1 from -200,321 million in 2023Q4 representing a change of 237.76%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q1 from 114 million in 2023Q4 representing a change of -100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 23,257 million in 2024Q1 from 55,226 million in 2023Q4 representing a change of -57.89%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 14,818 million in 2024Q1 from 36,435 million in 2023Q4 representing a change of -59.33%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -8,439 million in 2024Q1 from -18,791 million in 2023Q4 representing a change of 55.09%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 14,214 in 2024Q1 from -25,374 million in 2023Q4 representing a change of 156.02%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -20,981 million in 2024Q1 from 0 million in 2023Q4 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-03-31	2023-03-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	771.57	696.16	10.83
net income per share	199.91	113.22	76.57
operating cash flow per share	34.91	77.74	-55.09
free cash flow per share	-18.34	22.0	-183.40
cash per share	439.78	142.63	208.34
book value per share	624.03	506.16	23.29
tangible book value per share	399.62	271.18	47.36
shareholders equity per share	624.03	505.26	23.51
interest debt per share	255.42	274.88	-7.08
market cap	2651226601515	2937187088000	-9.74
enterprise value	2609909601515	3107915088000	-16.02
pe ratio	10.93	20.48	-46.63
price to sales ratio	2.83	3.33	-14.97
pocfratio	62.58	29.82	109.85
pfcf ratio	-119.11	105.4	-213.01
pb ratio	3.5	4.59	-23.70
ptb ratio	3.5	4.59	-23.70
ev to sales	2.79	3.52	-20.89
enterprise value over ebitda	24.17	13.01	85.75
ev to operating cash flow	61.61	31.56	95.23
ev to free cash flow	-117.25	111.53	-205.13
earnings yield	0.09	0.05	87.36
free cash flow yield	-0.01	0.01	-188.49
debt to equity	0.4	0.53	-25.52
debt to assets	0.2	0.23	-13.38
net debt to ebitda	-0.38	0.71	-153.53
current ratio	1.85	1.57	17.89
interest coverage	4.23	22.83	-81.47
income quality	0.11	0.52	-78.76
dividend yield	0.01	0.01	24.68
payout ratio	0.08	0.12	-33.45
sales general and administrative to revenue	0.51	0.48	6.00
research and ddevelopement to revenue	0.09	0.09	-1.11
intangibles to total assets	0.18	0.2	-10.08
capex to operating cash flow	1.53	0.72	112.73
capex to revenue	0.07	0.08	-13.80
capex to depreciation	0.98	1.06	-7.38
stock based compensation to revenue	0	0	NaN
graham number	1675.38	1134.51	47.67
roic	0.03	0.13	-78.29
return on tangible assets	0.19	0.12	62.24
graham net net	-0.17	-374.07	99.96
working capital	368645000000	264465000000	39.39
tangible asset value	484894000000	343546000000	41.14
net current asset value	23310000000	-140717000000	116.57
invested capital	900905000000	800884000000	12.49
average receivables	186135500000	176550000000	5.43
average payables	62387000000	61733000000	1.06
average inventory	176512000000	165181000000	6.86
days sales outstanding	77.04	72.29	6.57
days payables outstanding	65.18	80.56	-19.09
days of inventory on hand	200.25	208.69	-4.05
receivables turnover	4.74	5.05	-6.16
payables turnover	5.6	4.53	23.60
inventory turnover	1.82	1.75	4.22
roe	0.32	0.22	42.96
capex per share	53.26	55.75	-4.46

• Positive

  ROE: Return on Equity (ROE) increased to 0.32 on 2024-03-31 from 0.22 on 2023-03-31, representing a change of 42.96%. Suggesting the company has been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 1.85 on 2024-03-31 from 1.57 on 2023-03-31, representing a change of 17.89%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.40 on 2024-03-31 from 0.53 on 2023-03-31, representing a change of -25.52%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 10.93 on 2024-03-31 from 20.48 on 2023-03-31, representing a change of -46.63%. Indicating a decrease in the relative valuation of the company's stock.

• Quarterly Financial Ratios

	2024-09-30 Q2	2024-06-30 Q1	Q/Q change %
7733.T
calendar year	2024	2024	NaN
revenue per share	207.39	201.44	2.95
net income per share	29.82	12.51	138.37
operating cash flow per share	None	19.95	NaN
free cash flow per share	None	12.71	NaN
cash per share	238.33	243.99	-2.32
book value per share	609.57	677.75	-10.06
tangible book value per share	383.52	431.83	-11.19
shareholders equity per share	609.57	677.75	-10.06
interest debt per share	214.07	220.23	-2.80
market cap	3135573691775.5	2963811150945	5.80
enterprise value	3135186691775.5	2943957150945	6.50
pe ratio	22.79	50.81	-55.14
price to sales ratio	13.11	12.62	3.86
pocfratio	0	127.44	-100.00
pfcf ratio	0	200.01	-100.00
pb ratio	4.46	3.75	18.88
ptb ratio	4.46	3.75	18.88
ev to sales	13.11	12.54	4.54
enterprise value over ebitda	71.52	65.71	8.84
ev to operating cash flow	0	126.58	-100.00
ev to free cash flow	0	198.67	-100.00
earnings yield	0.01	0.0	122.94
free cash flow yield	None	0.0	NaN
debt to equity	0.35	0.32	8.36
debt to assets	0.18	0.17	6.93
net debt to ebitda	-0.01	-0.44	98.01
current ratio	1.57	1.76	-10.88
interest coverage	30.11	12.64	138.10
income quality	0	1.57	-100.00
dividend yield	None	0.01	NaN
payout ratio	None	1.44	NaN
sales general and administrative to revenue	0.5	0	NaN
research and ddevelopement to revenue	0	0.1	-100.00
intangibles to total assets	0.19	0.19	0.85
capex to operating cash flow	0	0.36	-100.00
capex to revenue	None	0.04	NaN
capex to depreciation	0	0.49	-100.00
stock based compensation to revenue	None	0	NaN
graham number	639.52	436.77	46.42
roic	0.03	0.01	149.72
return on tangible assets	0.03	0.01	162.05
graham net net	-255.54	-158.31	-61.41
working capital	237490000000	317429000000	-25.18
tangible asset value	442361000000	503391000000	-12.12
net current asset value	-6488000000	11295000000	-157.44
invested capital	747701000000	877002000000	-14.74
average receivables	107441500000	206241000000	-47.90
average payables	55807500000	59879000000	-6.80
average inventory	189119000000	190212500000	-0.57
days sales outstanding	0	82.36	-100.00
days payables outstanding	66.72	66.29	0.64
days of inventory on hand	233.32	217.97	7.04
receivables turnover	0	1.09	-100.00
payables turnover	1.35	1.36	-0.64
inventory turnover	0.39	0.41	-6.58
roe	0.05	0.02	165.03
capex per share	None	7.24	NaN

• Negative

  ROE: Return on Equity (ROE) increased to 0.05 on 2024-09-30 Q2 from 0.02 on 2024-06-30 Q1, representing a change of 165.03%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 22.79 on 2024-09-30 Q2 from 50.81 on 2024-06-30 Q1, representing a change of -55.14%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.57 on 2024-09-30 Q2 from 1.76 on 2024-06-30 Q1, representing a change of -10.88%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.35 on 2024-09-30 Q2 from 0.32 on 2024-06-30 Q1, representing a change of 8.36%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 1365.57 which is lower than current price 2290, indicates the company may be overvalued.